Key result
Admission kidney dysfunction and hypoxia linked to ~555% higher in-hospital mortality in COVID-19 patients.
Why the study?
Kidney dysfunction and hypoxia on admission are separately associated with COVID-19 mortality, but their combined impact in predicting mortality required further exploration.
Does the combination of kidney dysfunction and hypoxia on admission predict in-hospital mortality in COVID-19 patients?
Cohort (n=359)
Yes
Does the combination of kidney dysfunction and hypoxia on admission predict in-hospital mortality in COVID-19 patients?
The combination of kidney dysfunction and hypoxia on admission strongly predicts in-hospital mortality in COVID-19 patients, highlighting the need for early risk stratification.
Answers are grounded in this paper and cite their sources.
Admission KD and hypoxia may aid COVID-19 risk stratification; hypothesis-generating and requires prospective validation before clinical adoption.
Kidney dysfunction (KD) and hypoxia on admission are separately associated with COVID-19 mortality. Estimation of GFR using creatinine and peripheral oxygen saturation (SpO2) may be useful for stratification of at-risk populations. We performed a two centers retrospective cohort study of 359 COVID-19 patients aged 18 years or older to explore the impact of admission kidney function and hypoxia in predicting COVID-19 mortality. KD at admission was defined as estimated glomerular filtration rate (eGFR) calculated by CKD EPI < 60 mL /min/1.73 m2 using creatinine and hypoxia as a SpO2 ˂ 90%. Survival (time-to death) curves were built using the Kaplan–Meier methods. Association between mortality, hypoxia and KD was evaluated by multivariate Cox regression models with a significance level of the p-value set at 0.05. There were 152 patients (42.3%) with an eGFR < 60 mL/min/1.73 m2 and 208 patients (74.8%) with hypoxia on admission. Overall in-hospital mortality was 27.6%, rising to 59.7% in patients with eGFR below 60 mL/min and hypoxia (p < 0.001). Survival was lower in the group of patients with a eGFR below 60 mL/min/1.73 m2 and hypoxia (p < 0.001). Predictors of mortality were eGFR ≥ 60 mL/min/1.73 m2 with hypoxia (HR 2.05 [1.01–4.16], p = 0.048), eGFR < 60 mL/min/1.73 m2 without hypoxia (HR 3.20 [1.73–5.94], p < 0.001) and eGFR < 60 mL/min/1.73 m2 with hypoxia (HR 6.55 [3.63–11.84], p < 0.001). KD on admission and hypoxia are common in COVID-19. Its association with in-hospital mortality should encourage its use in the stratification of patients at risk of death. Influence of hypoxia could suggest a pattern of kidney-lung cross talk.
No takes yet. Share an insight, caveat, or question.
Nlandu et al. (2026) conducted a cohort in COVID-19 (n=359). Kidney dysfunction (eGFR < 60 mL/min/1.73 m2) with hypoxia vs. Normal kidney function without hypoxia was evaluated on in-hospital mortality (HR 6.55, 95% CI 3.63-11.84, p=<0.001). Admission kidney dysfunction combined with hypoxia in COVID-19 patients was associated with higher in-hospital mortality.
Synapse has enriched 10 related papers. Consider them for comparative context: